Related Experiment Video
Updated: Mar 25, 2026

Polymalic Acid-based Nano Biopolymers for Targeting of Multiple Tumor Markers: An Opportunity for Personalized Medicine?
Published on: June 13, 2014
Novel strategies for molecular targeting to cancer
Jun-Ping Liu1,2,3,4
1Institute of Ageing Research, Hangzhou Normal University School of Medicine, Hangzhou, Zhejiang Province, China.
Abstract:
This editorial draws attention to the work published by CEPP in 2014-2015 on mechanisms underlying cancer drug resistance, invasion and metastasis. Genetic, genomic and immunological changes in platinum drug resistance and new drug candidates for cancer metastasis are highlighted. Attention is paid to the Epimedium plant drug icariin in glioblastoma invasion, the plant Avicennia marina bioactive compound Naphtho[1,2-b]furan-4,5-dione in breast cancer metastasis, the PI3K inhibitor BEZ235 in colon cancer stem cells, the histone methyltransferase EZH1 inhibitor GSK343 in cervical cancer, and vitamin D3 in prostate cancer.
Insights
This review highlights research on cancer drug resistance, invasion, and metastasis mechanisms. It covers genetic, genomic, and immunological changes, plus novel drug candidates for various cancers.
Area of Science:
- Oncology
- Pharmacology
- Cancer Biology
Background:
- This editorial reviews CEPP's 2014-2015 publications on cancer drug resistance, invasion, and metastasis.
- It focuses on genetic, genomic, and immunological factors contributing to platinum drug resistance.
Discussion:
- Investigates novel therapeutic strategies targeting cancer metastasis.
- Examines the role of natural compounds like icariin (Epimedium) in glioblastoma invasion.
- Highlights Naphtho[1,2-b]furan-4,5-dione from Avicennia marina for breast cancer metastasis.
Key Insights:
- Discusses the PI3K inhibitor BEZ235 for colon cancer stem cells.
- Covers the EZH1 inhibitor GSK343 in cervical cancer treatment.
- Explores vitamin D3's potential in prostate cancer therapy.
Outlook:
- Suggests a need for further research into these drug candidates and mechanisms.
- Emphasizes the potential of natural products and targeted therapies in oncology.
- Underscores the importance of understanding drug resistance for effective cancer treatment.
More Related Videos
10:46A Flow Cytometry-Based Cell Surface Protein Binding Assay for Assessing Selectivity and Specificity of an Anticancer Aptamer
Published on: September 13, 2022
09:37Defining Gene Functions in Tumorigenesis by Ex vivo Ablation of Floxed Alleles in Malignant Peripheral Nerve Sheath Tumor Cells
Published on: August 25, 2021
Related Concept Videos
Targeted Cancer Therapies
There are several types of targeted therapies against...
Targeted Cancer Therapies
Treatment Resistant Cancers
Combination Therapies and Personalized Medicine
The combination of the drug acetazolamide and sulforaphane is a good example of combination therapy to treat cancer. The cells in the interior of a large tumor often die due to the hypoxic and...
Cancer Therapies
However, cancer treatments can pose several challenges, as therapies used to kill cancer cells are generally also toxic to normal cells. Moreover, cancer cells mutate rapidly and can develop resistance to chemical agents or radiation therapy. Besides, all types of cancer cells may not respond to the same therapy. Some cancer cells respond to one...
Tumor Immunotherapy